Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $972.30 | 48 | 74.2% |
| Long term medical supply or device loan | $299.10 | 3 | 22.8% |
| Education | $39.32 | 2 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $376.10 | 7 | $0 (2023) |
| Genentech, Inc. | $120.38 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $107.46 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $106.16 | 6 | $0 (2020) |
| Daiichi Sankyo Inc. | $91.47 | 5 | $0 (2022) |
| Genentech USA, Inc. | $72.01 | 4 | $0 (2020) |
| Amgen Inc. | $62.64 | 3 | $0 (2022) |
| Karyopharm Therapeutics Inc. | $38.67 | 1 | $0 (2020) |
| Puma Biotechnology, Inc. | $32.04 | 2 | $0 (2020) |
| Seagen Inc. | $29.57 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.82 | 3 | Genentech, Inc. ($120.38) |
| 2023 | $344.50 | 5 | Novartis Pharmaceuticals Corporation ($323.81) |
| 2022 | $77.40 | 4 | E.R. Squibb & Sons, L.L.C. ($24.50) |
| 2021 | $32.42 | 2 | Global Blood Therapeutics, Inc. ($17.88) |
| 2020 | $430.38 | 22 | AstraZeneca Pharmaceuticals LP ($56.38) |
| 2019 | $185.87 | 11 | Genentech USA, Inc. ($37.92) |
| 2018 | $97.33 | 6 | E.R. Squibb & Sons, L.L.C. ($30.21) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Genentech, Inc. | Itovebi (Biological) | Food and Beverage | In-kind items and services | $74.93 | General |
| Category: BioOncology | ||||||
| 11/15/2024 | Genentech, Inc. | Itovebi (Biological) | Food and Beverage | In-kind items and services | $45.45 | General |
| Category: BioOncology | ||||||
| 11/01/2024 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Oncology | ||||||
| 09/12/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: HEMATOLOGY | ||||||
| 05/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| 05/24/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Oncology | ||||||
| 02/15/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| 01/14/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| 11/10/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/10/2022 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Education | In-kind items and services | $24.50 | General |
| Category: Hematology | ||||||
| 04/27/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Oncology | ||||||
| 02/17/2022 | Astellas Pharma US Inc | Padcev (Drug) | Education | In-kind items and services | $14.82 | General |
| Category: Oncology | ||||||
| 11/19/2021 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, PIQRAY | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 08/04/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.49 | General |
| Category: Oncology | ||||||
| 07/08/2020 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 06/30/2020 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $21.00 | General |
| 06/24/2020 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Hematology | ||||||
| 06/10/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.40 | General |
| Category: Oncology | ||||||
| 06/09/2020 | Puma Biotechnology, Inc. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Bone Health | ||||||
| 06/01/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Oncology | ||||||
| 05/27/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Oncology | ||||||
| 05/19/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Anemia | ||||||
| 03/04/2020 | Genentech USA, Inc. | Avastin (Biological), Rituxan, Herceptin | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 352 | 625 | $191,300 | $57,755 |
| 2022 | 6 | 444 | 843 | $253,290 | $81,257 |
| 2021 | 6 | 401 | 732 | $173,972 | $69,659 |
| 2020 | 8 | 492 | 796 | $147,811 | $61,041 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 12 | $840.00 | $444.10 | 52.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 13 | $582.00 | $373.15 | 64.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 15 | $400.00 | $195.44 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 32 | 37 | $666.00 | $110.46 | 16.6% |
About Dr. Vikrant Brar, MD
Dr. Vikrant Brar, MD is a Hematology & Oncology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346447729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikrant Brar, MD has received a total of $1,311 in payments from pharmaceutical and medical device companies, with $142.82 received in 2024. These payments were reported across 53 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($972.30).
As a Medicare-enrolled provider, Brar has provided services to 1,689 Medicare beneficiaries, totaling 2,996 services with total Medicare billing of $269,711. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Richmond, VA
- Active Since 06/29/2007
- Last Updated 08/03/2016
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1346447729
Products in Payments
- Itovebi (Biological) $120.38
- INJECTAFER (Drug) $65.07
- OPDIVO (Biological) $50.35
- DARZALEX (Biological) $47.59
- Alecensa (Biological) $42.51
- XPOVIO (Drug) $38.67
- FASLODEX (Drug) $38.63
- CALQUENCE (Drug) $38.53
- EVENITY (Biological) $32.41
- NERLYNX (Drug) $32.04
- FOUNDATIONONE (Device) $28.31
- ALIMTA (Drug) $28.05
- ZEJULA (Drug) $26.61
- Enhertu (Drug) $26.40
- PIQRAY (Drug) $24.71
- Pomalyst (Drug) $24.50
- MONOFERRIC (Drug) $20.69
- REBLOZYL (Biological) $19.86
- TASIGNA (Drug) $18.79
- OXBRYTA (Drug) $17.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Richmond
Dr. Victor Yazbeck, M.d, M.D
Hematology & Oncology — Payments: $390,374
Attique Samdani, M.d, M.D
Hematology & Oncology — Payments: $146,382
Dr. Elke Friedman, Md, MD
Hematology & Oncology — Payments: $25,274
Dr. Asit Paul, M.d., Ph.d.,, M.D., PH.D.,
Hematology & Oncology — Payments: $7,490
Dr. Ghulam Qureshi, M.d, M.D
Hematology & Oncology — Payments: $7,032
Gisa-Beate Schunn, M.d, M.D
Hematology & Oncology — Payments: $5,929